Form 4: Thomas F. Frist III Reports Acquisition of HCA Healthcare Shares Through Director Equity Award

Thomas F. Frist III, a director at HCA Healthcare, reported acquiring 1,284 shares of common stock due to a director equity award and shares received in lieu of cash retainers.

Summary

• On April 29, 2024, Thomas F. Frist III, a director of HCA Healthcare, Inc., acquired 1,284 shares of common stock.
• These shares were obtained through a director equity award and restricted share units received in place of annual cash retainers.
• The restricted share units will vest on the earlier of the 2025 annual shareholders' meeting or the first anniversary of the grant date.
• Frist also has indirect ownership through various entities, including Hercules Holding II, trusts for children, and Frisco, Inc.
• He disclaims beneficial ownership of shares held by Hercules, except to the extent of his pecuniary interest.
• As of the report, Frist directly owns 13,497 shares and has indirect ownership of millions more through various entities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing reporting a director's acquisition of shares, which is neither overtly positive nor negative.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.
• The director equity award aligns the director's interests with those of the shareholders.

Future Outlook

The restricted share units will vest on the sooner of the date of the 2025 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the ownership changes of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's investment in the company.

Key Dates